Amgen: Biotech Giant's Path to Growth and Recovery
Amgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
Review fee comparisons across wide market index funds to find the lowest-cost option for retirement. Practical guidance to reduce recurring expenses.
28,610 articlesAmgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
Rocket Lab and AST SpaceMobile pursue different spacefrontiers, from reliable launches to space-based connectivity. T...
SUI jumped 35% over the past week, topping the top-10 digital assets. A large stake reshaped supply while new futures...
When a public relationship sparks a wedding plan, the financial side is as big a story as the romance. Here’s how to ...
When an EBT scam drained a Bridgeport mother's SNAP funds, two local business owners stepped in to replace her month ...
UBS uMINT yield-bearing collateral is now live on Bybit through a three‑party workflow, turning idle cash into produc...
A top market analyst says the popular rotation narrative is flawed. New ETF flow data show bitcoin didn’t lose gold, ...
A bold new AI model from Z.AI promises high performance without Nvidia chips. This article breaks down what GLM-5.2 m...
HUD launches two tech-enabled pilots designed to increase housing supply and cut costs. The programs target robotics ...
Life360 faced a tough week as investors digested a mixed earnings report. This article explains the drivers behind th...
Automotive AI software leads the market today as BlackBerry and Mobileye rally on platform milestones, while NVIDIA d...
Tech markets are split: cybersecurity chip stocks soaring as AI chips gain traction, even as software stocks wobble. ...